Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It appears to me the appointment to the BOD of Mr. Schrock is
I am thinking the same. Perhaps what the shareholders have been unable to do, the new board will do! I hope if such a scenario takes place the improved board of directors will operate with the shareholders best interest in mind. That may or may not happen even with a new board. If not then at least with the intention of increasing the value of the company and dramatically increasing the share price. Of course if they are shareholders in great numbers I would think share price appreciation will be in their best interest as well and most likely to happen. GLTAL
Share
New Message
Please login to post a reply